We are live on ! Find out more
CDLX icon

Cardlytics
CDLX

Fund managers haven’t disclosed any holdings of CDLX yet.

CDLX Hedge Fund Activity: Q1 2026 in Review

58 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q1 2026, worth a combined $18.1M — down 28% from $25.1M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of CDLX and 12 opened new positions — a net loss of 9 holders — while 19 trimmed existing stakes and 9 added.

The largest buyer was HRT Financial, opening a new position worth an estimated $143K. The largest seller was Bank of America, cutting an estimated $1.39M.

  • 58 institutional investors held Cardlytics (CDLX) as of Q1 2026, down from 70 in Q4 2025.
  • Funds reported $18.1M of Cardlytics stock for Q1 2026, down 28% quarter-over-quarter.
  • 12 funds opened new Cardlytics positions in Q1 2026 and 21 closed out, a net change of -9 holders.
  • The largest Cardlytics buyer in Q1 2026 was HRT Financial, an estimated $143K added.
  • The largest Cardlytics seller in Q1 2026 was Bank of America, an estimated $1.39M sold.

Based on aggregated 13F filings for Q1 2026.